ES484074A1 - Un procedimiento de preparacion de nuevas cefalosporinas - Google Patents
Un procedimiento de preparacion de nuevas cefalosporinasInfo
- Publication number
- ES484074A1 ES484074A1 ES484074A ES484074A ES484074A1 ES 484074 A1 ES484074 A1 ES 484074A1 ES 484074 A ES484074 A ES 484074A ES 484074 A ES484074 A ES 484074A ES 484074 A1 ES484074 A1 ES 484074A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- carboxymethyloxyimino
- ceph
- eme
- acetamido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- MSCHWTRLKGAEQT-FFFFSGIJSA-N (6R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical class NC=1SC=C(N=1)C(C(=O)NC1[C@@H]2N(C(=CCS2)C(=O)O)C1=O)=NOCC(=O)O MSCHWTRLKGAEQT-FFFFSGIJSA-N 0.000 title abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 3
- 230000003000 nontoxic effect Effects 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 2
- 150000001340 alkali metals Chemical class 0.000 abstract 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001412 amines Chemical class 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 229910052749 magnesium Inorganic materials 0.000 abstract 2
- 239000011777 magnesium Substances 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910052757 nitrogen Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
1. Un procedimiento de preparación de nuevas cefalosporinas de fórmula general I **(Fórmula)** isómero sin, donde R representa un radical alcohilo que tiene de 1 a 3 átomos de carbono, o un radical -CH2-S-R1, donde R1 representa un heterociclo de 5 o 6 eslabones que comprende de 1 a 4 heteroátomos elegidos entre azufre, oxígeno y nitrógeno eventualmente sustituido, A representa un átomo de hidrógeno o un equivalente de metal alcalino, alcalinotérreo, magnesio, amonio o una base orgánica aminada, o A representa un grupo éster fácilmente escindible, A1 representa un radical alcohilo que tiene de 1 a 3 átomos de carbono, un átomo de hidrógeno o un equivalente de metal alcalino, alcalinotérreo, magnesio, amonio o una base orgánica aminada, o A1 representa un grupo éster fácilmente escindible, así como sales de productos de fórmula I con ácidos minerales u orgánicos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7810387A FR2421907A1 (fr) | 1978-04-07 | 1978-04-07 | Nouvelles cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl)2-(carboxymethoxyimino/acetamido 3-substitue cephalosporanique, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES484074A1 true ES484074A1 (es) | 1980-06-16 |
Family
ID=9206849
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES479273A Expired ES479273A1 (es) | 1978-04-07 | 1979-04-04 | Un procedimiento de preparacion de nuevas cefalosporinas. |
| ES484074A Expired ES484074A1 (es) | 1978-04-07 | 1979-09-11 | Un procedimiento de preparacion de nuevas cefalosporinas |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES479273A Expired ES479273A1 (es) | 1978-04-07 | 1979-04-04 | Un procedimiento de preparacion de nuevas cefalosporinas. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4287193A (es) |
| JP (1) | JPS54135793A (es) |
| AT (1) | AT365194B (es) |
| BE (1) | BE875379A (es) |
| CH (1) | CH639388A5 (es) |
| DE (1) | DE2914060A1 (es) |
| ES (2) | ES479273A1 (es) |
| FR (1) | FR2421907A1 (es) |
| GB (1) | GB2021561B (es) |
| IT (1) | IT1162463B (es) |
| NL (1) | NL7902784A (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE878514A (fr) * | 1978-09-04 | 1980-02-29 | Fujisawa Pharmaceutical Co | Procede de preparation de composes d'acide 3-cephem-4-carboxylique a disubstitution en positions 3 et 7, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne |
| US4284631A (en) * | 1978-07-31 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them |
| FR2462439A1 (fr) * | 1979-07-26 | 1981-02-13 | Roussel Uclaf | Nouveau procede de preparation de produits derives de l'acide 7-/(2-aryl) 2-hydroxyimino acetamido/cephalosporanique |
| DK416681A (da) * | 1980-09-26 | 1982-03-27 | Fujisawa Pharmaceutical Co | Femgangsmaade til fremstilling af cephemforbindelser |
| US4507293A (en) * | 1980-09-26 | 1985-03-26 | Fujisawa Pharmaceutical Co., Ltd. | Antimicrobial cephem compounds |
| EP0055465B1 (en) | 1980-12-31 | 1989-08-23 | Fujisawa Pharmaceutical Co., Ltd. | 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof |
| IE53429B1 (en) * | 1981-08-03 | 1988-11-09 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
| GB8410992D0 (en) * | 1984-04-30 | 1984-06-06 | Glaxo Group Ltd | Process |
| CA2054126A1 (en) * | 1990-10-26 | 1992-04-27 | Michiyuki Sendai | Cephem compounds, their production and use |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4092477A (en) * | 1971-05-14 | 1978-05-30 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins |
| US4095021A (en) * | 1973-12-21 | 1978-06-13 | Glaxo Laboratories Limited | 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof |
| DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| FR2345153A1 (fr) * | 1976-03-25 | 1977-10-21 | Roussel Uclaf | Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
| US4166115A (en) * | 1976-04-12 | 1979-08-28 | Fujisawa Pharmaceutical Co., Ltd. | Syn 7-oxoimino substituted derivatives of cephalosporanic acid |
| GB1576625A (en) * | 1976-04-12 | 1980-10-08 | Fujisawa Pharmaceutical Co | Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof |
| DK162391C (da) * | 1976-04-12 | 1992-03-09 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af syn-isomerer af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser |
| US4066762A (en) * | 1976-07-12 | 1978-01-03 | Smithkline Corporation | Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid |
| AU510280B2 (en) * | 1976-08-30 | 1980-06-19 | Bristol-Myers Company | Antibacterial cephalosporin agents |
| GB1592149A (en) * | 1976-10-08 | 1981-07-01 | Fujisawa Pharmaceutical Co | 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof |
| PH17188A (en) * | 1977-03-14 | 1984-06-14 | Fujisawa Pharmaceutical Co | New cephem and cepham compounds and their pharmaceutical compositions and method of use |
| SE439312B (sv) * | 1977-03-25 | 1985-06-10 | Roussel Uclaf | Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra |
| DE2716677C2 (de) * | 1977-04-15 | 1985-10-10 | Hoechst Ag, 6230 Frankfurt | Cephemderivate und Verfahren zu ihrer Herstellung |
| DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
-
1978
- 1978-04-07 FR FR7810387A patent/FR2421907A1/fr active Granted
-
1979
- 1979-04-03 US US06/026,767 patent/US4287193A/en not_active Expired - Lifetime
- 1979-04-04 ES ES479273A patent/ES479273A1/es not_active Expired
- 1979-04-05 AT AT0255279A patent/AT365194B/de not_active IP Right Cessation
- 1979-04-05 IT IT48631/79A patent/IT1162463B/it active
- 1979-04-06 CH CH327779A patent/CH639388A5/fr not_active IP Right Cessation
- 1979-04-06 JP JP4113879A patent/JPS54135793A/ja active Granted
- 1979-04-06 DE DE19792914060 patent/DE2914060A1/de active Granted
- 1979-04-06 BE BE0/194450A patent/BE875379A/xx not_active IP Right Cessation
- 1979-04-09 NL NL7902784A patent/NL7902784A/xx not_active Application Discontinuation
- 1979-04-09 GB GB7912432A patent/GB2021561B/en not_active Expired
- 1979-09-11 ES ES484074A patent/ES484074A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ATA255279A (de) | 1981-05-15 |
| FR2421907A1 (fr) | 1979-11-02 |
| JPS6360758B2 (es) | 1988-11-25 |
| US4287193A (en) | 1981-09-01 |
| NL7902784A (nl) | 1979-10-09 |
| GB2021561B (en) | 1982-11-17 |
| JPS54135793A (en) | 1979-10-22 |
| CH639388A5 (fr) | 1983-11-15 |
| IT7948631A0 (it) | 1979-04-05 |
| DE2914060A1 (de) | 1979-10-18 |
| FR2421907B1 (es) | 1981-07-24 |
| BE875379A (fr) | 1979-10-08 |
| ES479273A1 (es) | 1979-12-01 |
| DE2914060C2 (es) | 1991-01-24 |
| GB2021561A (en) | 1979-12-05 |
| AT365194B (de) | 1981-12-28 |
| IT1162463B (it) | 1987-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES477592A1 (es) | Procedimiento de preparacion de nuevas oximas derivadas del acido 3-acetoximetil-7-aminotiazolil-acetamido-cefalospora- nico. | |
| ES8704955A1 (es) | Un proceso para la produccion de un compuesto de cefalospo- rina | |
| ES479273A1 (es) | Un procedimiento de preparacion de nuevas cefalosporinas. | |
| ES486824A1 (es) | Procedimiento para la preparacion de nuevos derivados de 4- (naftilmetil) piperidinas | |
| ES8304142A1 (es) | "procedimiento para preparar productos derivados del acido 2-amino-tiazolil-2-oxiimino-acetamido-biciclo-octeno-carboxilico". | |
| IE44857L (en) | Cephalosporin derivatives. | |
| ES445348A1 (es) | Un procedimiento para preparar compuestos de 3-aciloximetil-cefem. | |
| SE8003466L (sv) | Alkyloximsubstituerade 7-(2-amino-4-tiazolyl)-acetamido-cefalosporansyraderivat, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar | |
| IE44014L (en) | Amino-benzocycloheptenes. | |
| PT87945A (pt) | Processo para a preparacao de novos derivados de cefalosporina | |
| ES479037A1 (es) | Procedimiento de preparacion de nuevas oximas derivadas del acido 7-amino-tiazolil-acetamido-cefalosporanico. | |
| ES8506318A1 (es) | Un procedimiento para preparar derivados de cefalosporina | |
| ES8500953A1 (es) | Procedimiento para preparar derivados de tieno-tiazol | |
| PH21127A (en) | Process for the manufacture of aminothiazole acid derivative | |
| ES484224A1 (es) | Un procedimiento de preparacion de nuevas oximas derivadas del acido 3-azidometil-7-amino-tiazolil-acetamido-cefalospo-ranico | |
| AU576840B2 (en) | 1,2,4-thiadiazines | |
| ES447615A1 (es) | Un procedimiento para obtener compuesto de cefalosporina. | |
| AU551901B2 (en) | Substituted thienobenzodiazepinones | |
| IE44999L (en) | Hydrazinopyridazine derivatives. | |
| IE44029L (en) | Cephalosporin derivatives. | |
| ES445149A1 (es) | Procedimiento de preparacion de nuevos derivados de 5-tia- zol-alcanoles. | |
| DE3066808D1 (en) | Clavulanic acid derivatives, their preparation and pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970203 |